Oramed Pharma (ORMP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,924 | -3,611 | -37,764 | -29,028 | -21,775 |
| Depreciation Amortization | 89 | 37 | 58 | 41 | 26 |
| Other Working Capital | -4,062 | -816 | -943 | 609 | -1,833 |
| Other Operating Activity | 714 | -1,159 | 10,731 | 8,522 | 5,967 |
| Operating Cash Flow | $-8,183 | $-5,549 | $-27,918 | $-19,856 | $-17,615 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -27,694 | -13,004 | 26,500 | 21,836 | 17,786 |
| PPE Investments | -219 | -199 | -472 | -188 | -67 |
| Purchase Of Investment | N/A | N/A | -2,705 | -2,700 | N/A |
| Other Investing Activity | 0 | 0 | 6,888 | 3 | 3 |
| Investing Cash Flow | $-27,913 | $-13,203 | $30,211 | $18,951 | $17,722 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 2,430 | 2,430 | 11,562 | 7,387 | 2,968 |
| Other Financing Activity | 0 | 0 | -783 | -783 | -677 |
| Financing Cash Flow | $2,430 | $2,430 | $10,779 | $6,604 | $2,291 |
| Exchange Rate Effect | -31 | -38 | -64 | 41 | 38 |
| Beginning Cash Position | 40,464 | 40,464 | 27,456 | 27,456 | 27,456 |
| End Cash Position | 6,767 | 24,104 | 40,464 | 33,196 | 29,892 |
| Net Cash Flow | $-33,697 | $-16,360 | $13,008 | $5,740 | $2,436 |
| Free Cash Flow | |||||
| Operating Cash Flow | -8,183 | -5,549 | -27,918 | -19,856 | -17,615 |
| Capital Expenditure | -219 | -199 | -496 | -188 | -67 |
| Free Cash Flow | -8,402 | -5,748 | -28,414 | -20,044 | -17,682 |